MCQ Collection

Australia & New Zealand MCQs

Practice Australia & New Zealand questions with answers and explanations.

ucat-anz-decision Decision Making Australia & New ZealandMedium

Reasoning scenario 1: A healthcare selection panel is testing formal inference, evidence appraisal and decision quality. The setting is an outpatient service. Analyst Y6 finishes before Analyst Z7, and Analyst Z7 before Analyst A8. Which statement must be true?

Choose an option to check your answer.

ucat-anz-decision Decision Making Australia & New ZealandMedium

Reasoning scenario 2: A healthcare selection panel is testing formal inference, evidence appraisal and decision quality. The setting is a screening programme. Among 120 applications, 53 require check A, 61 require check B, and 20 require both. How many require A or B?

Choose an option to check your answer.

ucat-anz-decision Decision Making Australia & New ZealandMedium

Reasoning scenario 3: A healthcare selection panel is testing formal inference, evidence appraisal and decision quality. The setting is a clinical audit team. All sovins are pelans. No pelan is a jovin. Which conclusion follows?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 238: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. In antimicrobial comparison 238, which distinction is correct?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 239: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. Which statement best describes Phase I metabolism for compound series 239?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandHard

Science task 240: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. A product follows first-order degradation with k=0.018 day⁻¹ for 29 days. Approximately what percentage remains?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandHard

Science task 228: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. A product follows first-order degradation with k=0.012 day⁻¹ for 17 days. Approximately what percentage remains?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 229: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. Which statement is most accurate for clinical study 229?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 230: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. A diagnostic test has sensitivity 74% and specificity 83%. Which statement about positive predictive value is correct?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 231: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. For dosage-form design case 231, what is a typical purpose of a depot formulation?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 232: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. A drug amount of 662 mg is distributed in an apparent volume of 51 L. What is the estimated plasma concentration?

Choose an option to check your answer.

opra OPRA Pharmaceutical Sciences Australia & New ZealandMedium

Science task 233: An overseas-trained pharmacist is applying pharmaceutical science to a safe medicines-use decision. An oral dose is 132 mg with bioavailability 0.7 and clearance 7 L/h. Using AUC=F×Dose/CL, what is AUC?

Choose an option to check your answer.